BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7910742)

  • 1. Drugs of abuse: biochemical surrogates of specific aspects of natural reward?
    Di Chiara G; Acquas E; Tanda G; Cadoni C
    Biochem Soc Symp; 1993; 59():65-81. PubMed ID: 7910742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain mechanisms of drug reward and euphoria.
    Wise RA; Bozarth MA
    Psychiatr Med; 1985; 3(4):445-60. PubMed ID: 2893431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural mechanisms of the reinforcing action of cocaine.
    Wise RA
    NIDA Res Monogr; 1984; 50():15-33. PubMed ID: 6440023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addictive drugs and brain stimulation reward.
    Wise RA
    Annu Rev Neurosci; 1996; 19():319-40. PubMed ID: 8833446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine D3 receptor and drug dependence: effects on reward or beyond?
    Le Foll B; Goldberg SR; Sokoloff P
    Neuropharmacology; 2005 Sep; 49(4):525-41. PubMed ID: 15963538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine.
    Salamone JD; Correa M; Mingote SM; Weber SM
    Curr Opin Pharmacol; 2005 Feb; 5(1):34-41. PubMed ID: 15661623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects.
    Pistis M; Muntoni AL; Pillolla G; Perra S; Cignarella G; Melis M; Gessa GL
    Neuroscience; 2005; 131(2):465-74. PubMed ID: 15708487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CART in the reward/reinforcing properties of psychostimulants.
    Jaworski JN; Jones DC
    Peptides; 2006 Aug; 27(8):1993-2004. PubMed ID: 16766084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat.
    Fadda P; Scherma M; Fresu A; Collu M; Fratta W
    Synapse; 2003 Oct; 50(1):1-6. PubMed ID: 12872287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse.
    Tassin JP
    Biochem Pharmacol; 2008 Jan; 75(1):85-97. PubMed ID: 17686465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
    Le Foll B; Goldberg SR
    J Pharmacol Exp Ther; 2005 Mar; 312(3):875-83. PubMed ID: 15525797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous opioids and addiction to alcohol and other drugs of abuse.
    Gianoulakis C
    Curr Top Med Chem; 2004; 4(1):39-50. PubMed ID: 14754375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure.
    Barbier E; Pierrefiche O; Vaudry D; Vaudry H; Daoust M; Naassila M
    Neuropharmacology; 2008 Dec; 55(7):1199-211. PubMed ID: 18713641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid reward mechanisms: a key role in drug abuse?
    Herz A
    Can J Physiol Pharmacol; 1998 Mar; 76(3):252-8. PubMed ID: 9673788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of metabotropic glutamate receptors in drug reward, motivation and dependence.
    Markou A
    Drug News Perspect; 2007 Mar; 20(2):103-8. PubMed ID: 17440633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs of abuse and the brain.
    Leshner AI; Koob GF
    Proc Assoc Am Physicians; 1999; 111(2):99-108. PubMed ID: 10220804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ, hedonic state and the response to abused drugs.
    Murphy NP
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):295-8. PubMed ID: 15658507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.